B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple SclerosisNEJM 358:676-688, Hauser,S.L.,et al, 2008
Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008